CY7-11317-50716
4 vaccinations
3 coded responses
29 check-ins
3 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 66+
- ZIP prefix
- 107 / NY
- Registered
- 2021-01-21
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2020-12-28
Dose 1 — Pfizer-BioNTech
-
2021-01-18
Dose 2 — Pfizer-BioNTech
-
2021-01-21
Registered in v-safe
-
2021-01-21
Survey response — days 1–6 daily, dose 2MedDRA: Eye discharge, Respiratory tract congestion, Rhinorrhoea, Sneezing — Feeling: FairFree text: woke up at 2am with sneezing, right nostril and right eye running profusely. Right sinus felt very congested. Had same symptoms occur early am of January 1,2021.d eyeMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-01-22
- 2021-01-24
- 2021-01-25
- 2021-02-01
- 2021-02-08
- 2021-02-15
- 2021-02-22
- 2021-03-01
- 2021-04-19
- 2021-07-19
-
2021-10-04
Dose 3 — Pfizer-BioNTech
- 2021-10-04
-
2021-10-05
Health check-in — days 1–6 daily, dose 3Feeling: Fair · Site: Swelling · Joint pains, Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-10-06
- 2021-10-07
- 2021-10-08
- 2021-10-09
- 2021-10-10
- 2021-10-11
- 2021-10-18
- 2021-10-25
- 2021-11-01
- 2021-11-08
- 2021-11-15
- 2022-01-03
-
2022-04-01
Dose 4 — Pfizer-BioNTech
-
2022-04-04
Survey response — 6 months, dose 3MedDRA: Eye discharge, Rhinorrhoea, Sneezing, Vaccine positive rechallenge — Feeling: Good · Be unable to do your normal daily activitiesFree text: Had excessive sneezing and profuse watery dischage from nose and eyes starting about 5 hrs. after 2nd covelid booster on Friday,4/1/22. Lasted about 20 hrs. and then stopped. Same symptons occurred only after my initial covid jab on 12/28/20.MedDRA releases: 2024-11 · check-in free text available
- 2022-05-18
-
2022-07-01
Survey response — 3 months, dose 4MedDRA: Malignant melanoma in situ, Skin neoplasm excision — Feeling: GoodFree text: Melanoma in situ on my back. Status post removal but 1 margin requires revision.MedDRA releases: 2024-11 · check-in free text available
- 2023-04-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-28 | Pfizer-BioNTech | |
| 2 | 2021-01-18 | Pfizer-BioNTech | |
| 3 | 2021-10-04 | Pfizer-BioNTech | No |
| 4 | 2022-04-01 | Pfizer-BioNTech | No |
Free text
Release 2 — days 1–6 daily, dose 2
Systemic reaction (other): woke up at 2am with sneezing, right nostril and right eye running profusely. Right sinus felt very congested. Had same symptoms occur early am of January 1,2021.d eye
Release 11 — 6 months, dose 3
Symptoms: Had excessive sneezing and profuse watery dischage from nose and eyes starting about 5 hrs. after 2nd covelid booster on Friday,4/1/22. Lasted about 20 hrs. and then stopped. Same symptons occurred only after my initial covid jab on 12/28/20.
Release 12 — 3 months, dose 4
Symptoms: Melanoma in situ on my back. Status post removal but 1 margin requires revision.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Eye discharge | · | · | ✓ |
| SD | Malignant melanoma in situ | · | · | ✓ |
| SD | Rhinorrhoea | · | · | ✓ |
| SD | Skin neoplasm excision | · | · | ✓ |
| SD | Sneezing | · | · | ✓ |
| SD | Vaccine positive rechallenge | · | · | ✓ |
| SRO | Eye discharge | ✓ | ✓ | ✓ |
| SRO | Respiratory tract congestion | ✓ | ✓ | ✓ |
| SRO | Rhinorrhoea | ✓ | ✓ | ✓ |
| SRO | Sneezing | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release